gamma-endorphin--des-tyr(1)- and beta-endorphin-(2-9)

The effect of the non-opiate beta-endorphin (beta E) fragment 2-9 and related peptides on immunoreactive (IR) arginine8 -vasopressin (AVP) levels was studied in the rat eye plexus plasma. Additionally, the effect of beta E 2-9 on AVP release from pituitary neurointermediate lobes ( NILs ), in vitro was studied. IR AVP levels in the eye plexus plasma increased after subcutaneous (s.c.) injection of beta E 2-9. In female rats peak values were observed 2 min after the administration of beta E 2-9 (10 micrograms/rat). Male rats were 100 times more sensitive than female rats. A dose-response study revealed a U-shaped relationship for this effect of beta E 2-9 in animals of both sexes. From structure-activity studies it appeared that beta E 2-9 was the most effective fragment. Intracerebroventricular (i.c.v.) administration of beta E 2-9 did not affect the IR-AVP levels in eye plexus plasma. Moreover, AVP release from the rat NILs cells in vitro was stimulated by perfusion with beta E 2-9, indicating a direct effect of the peptide on the pituitary. Therefore we suggest that beta E 2-9 increases AVP release by a direct action on the posterior pituitary.

Topics: Animals; Arginine Vasopressin; beta-Endorphin; Endorphins; Female; Male; Peptide Fragments; Pituitary Gland, Posterior; Radioimmunoassay; Rats; Rats, Inbred Strains; Structure-Activity Relationship